Search results
Results from the WOW.Com Content Network
McKesson ANZ is a fully owned subsidiary of McKesson Corporation. McKesson expanded its footprint in Australia and New Zealand by acquiring Emendo in November 2012. [63] McKesson ANZ develops and sells healthcare optimization services and software. The company has traditionally been focused on the public markets in Australia and New Zealand.
The acquisition includes IOmets indoleamine-2,3-dioxygenase 1 (IDO), tryptophan 2,3-dioxygenase (TDO), and dual-acting inhibitors. [ 99 ] In July 2016, the company acquired Afferent Pharmaceuticals, developer of a candidate used to block P2RX3 receptors, for approximately $1 billion, plus up to $750 million in milestone payments.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more
McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better.
On Wednesday, health-care services and IT firm McKesson Corporation (NYS: MCK) confirmed it has received notification of the early termination of the Hart-Scott-Rodino waiting period required ...
McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close of the transaction, Florida Cancer Specialists — which operates in ...
In 1996, McKesson Corporation acquired FoxMeyer drug company. With this acquisition came the Health Mart franchise, which started with several hundred pharmacies. [1] Since McKesson's acquisition of Health Mart, the franchise has expanded rapidly and received many awards from leading pharmaceutical industry publications.
McKesson announced its results for the most recent quarter on Thursday. After beating analyst estimates for several consecutive quarters, the health care services giant announced earnings that ...